中文 | English
Return
Total: 571 , 1/58
Show Home Prev Next End page: GO
Author:(Jun-ying MA)

1.Xuefu Zhuyutang Ameliorates Metabolic-associated Fatty Liver Disease via AMPK Signaling Pathway

Ming HAN ; Ying ZHANG ; Lingya KONG ; Jun DAI ; Ting ZHANG ; Zhihong MA

Chinese Journal of Experimental Traditional Medical Formulae 2026;32(11):1-12

2.Construction of a renal rehabilitation, diagnosis and quality control information platform

Ying SHI ; Xiaomeng SUN ; Jun CHENG ; Di CHEN ; Yifan TIAN ; Yingchun MA ; Xinxin WANG ; Haiyan YE

Chinese Journal of Rehabilitation Theory and Practice 2026;32(4):488-496

3.Development and preliminary internal validation of a prediction model for brace treatment failure in adolescent idiopathic scoliosis using pretreatment and initial brace-fitting information

Ying MA ; Jun REN ; Shoujian WANG ; Xin ZHOU ; Tianxiang HE ; Lingjun KONG ; Min FANG

Chinese Journal of Rehabilitation Theory and Practice 2026;32(7):850-860

4.Effects of Quhan Zhufeng Mixture in Regulating NDRG2/JAK2/STAT3 Signaling Pathway on the Proliferation and Apoptosis of RA-FLS

Xiaojun SU ; Wenju ZHU ; Ying GUO ; Huan WANG ; Qian HE ; Zhiming ZHANG ; Xuemei TIAN ; Haili SHEN ; Jun MA ; Qiang BAO

Chinese Journal of Information on Traditional Chinese Medicine 2025;32(7):119-126

5.Related factors of cognitive impairment in middle-aged and old-aged patients with type 2 diabetes mellitus

Jiayu WANG ; Yangfan CHAI ; Qirun LI ; Jun MA ; Ying GAO ; Wei LIU ; Youyuan HUANG ; Yan ZHANG ; Jia JIA ; Shuyu WANG ; Wenbo WANG ; Liguang DONG ; Anping WANG ; Yingkui SI ; Guilan KONG ; Jian ZHANG ; Junqing ZHANG

Chinese Mental Health Journal 2025;39(1):13-19

6.Effects of Quhan Zhufeng Mixture in Regulating NDRG2/JAK2/STAT3 Signaling Pathway on the Proliferation and Apoptosis of RA-FLS

Xiaojun SU ; Wenju ZHU ; Ying GUO ; Huan WANG ; Qian HE ; Zhiming ZHANG ; Xuemei TIAN ; Haili SHEN ; Jun MA ; Qiang BAO

Chinese Journal of Information on Traditional Chinese Medicine 2025;32(7):119-126

7.Application of SWOT analysis-guided risk control management in patients with atherosclerotic obliter-ans

Wei SU ; Mei WANG ; Ying-hao MA ; Juan ZHOU ; Jun-ying LU

Chinese Journal of cardiovascular Rehabilitation Medicine 2025;34(1):86-91

8.Treatment and mechanism of chrysoeriol on pulmonary hypertension based on network pharmacology and experimental study

Ying-fang MA ; Meng CAI ; Dan FENG ; Yang GUO ; Yu-he TIAN ; Yun-hua ZHANG ; Li-li WEI ; Yang WANG ; Jun-qiang SI

Chinese Pharmacological Bulletin 2025;41(11):2167-2176

9.Treatment of hypertensive nephropathy based on"five viscera in one"view

Hong WANG ; Lu-fan SHEN ; Rui-ling MA ; Ming-shuang HOU ; Hong-ying LÜ ; Guan-jun JIA ; Lin YI

The Chinese Journal of Clinical Pharmacology 2025;41(1):121-126

10.Related factors of cognitive impairment in middle-aged and old-aged patients with type 2 diabetes mellitus

Jiayu WANG ; Yangfan CHAI ; Qirun LI ; Jun MA ; Ying GAO ; Wei LIU ; Youyuan HUANG ; Yan ZHANG ; Jia JIA ; Shuyu WANG ; Wenbo WANG ; Liguang DONG ; Anping WANG ; Yingkui SI ; Guilan KONG ; Jian ZHANG ; Junqing ZHANG

Chinese Mental Health Journal 2025;39(1):13-19

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 571 , 1/58 Show Home Prev Next End page: GO